39P Evaluation of body mass composition (BMC) changes in metastatic ALK-positive non-small cell lung cancer (ALK-mNSCLC) patients treated with anti-ALK tyrosine kinase inhibitors (aALK-TKIs): Preliminary results
ESMO Open(2024)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要